News stories about Utah Medical Products (NASDAQ:UTMD) have been trending somewhat positive this week, Accern Sentiment reports. Accern ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Utah Medical Products earned a coverage optimism score of 0.06 on Accern’s scale. Accern also assigned media headlines about the medical instruments supplier an impact score of 45.8367272662045 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Shares of Utah Medical Products (NASDAQ UTMD) opened at 73.05 on Tuesday. The firm’s 50 day moving average price is $71.73 and its 200-day moving average price is $67.37. Utah Medical Products has a 1-year low of $56.30 and a 1-year high of $75.00. The company has a market capitalization of $271.67 million, a P/E ratio of 20.95 and a beta of 0.74.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 3rd. Stockholders of record on Friday, September 15th will be issued a $0.265 dividend. This represents a $1.06 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Thursday, September 14th. Utah Medical Products’s dividend payout ratio is presently 30.37%.

A number of equities research analysts have issued reports on UTMD shares. ValuEngine upgraded Utah Medical Products from a “sell” rating to a “hold” rating in a research note on Tuesday, June 6th. BidaskClub downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th.

WARNING: This news story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/09/19/utah-medical-products-utmd-receiving-somewhat-positive-news-coverage-analysis-shows.html.

About Utah Medical Products

Utah Medical Products, Inc (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts.

Insider Buying and Selling by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Stock Ratings for Utah Medical Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products Inc. and related stocks with our FREE daily email newsletter.